{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:51:14Z","timestamp":1785390674047,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Coeliac disease (CD) is a common and complex disorder of the small intestine caused by intolerance to wheat gluten and related edible cereals like barley and rye. Peptides originating from incomplete gliadin digestion activate the lamina propria infiltrating T cells to release proinflammatory cytokines, which in turn cause profound tissue remodelling of the small intestinal wall. There is no cure for CD except refraining from consuming gluten-containing products.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Phage from a random oligomer display library were enriched by repeated pannings against immobilised gliadin proteins. Phage from the final panning round were plated, individual plaques picked, incubated with host bacteria, amplified to a population size of 10<jats:sup>11<\/jats:sup> to 10<jats:sup>12<\/jats:sup> and purified. DNA was isolated from 1000 purified phage populations and the region covering the 36 bp oligonucleotide insert from which the displayed peptides were translated, was sequenced. Altogether more than 150 different peptide-encoding sequences were identified, many of which were repeatedly isolated under various experimental conditions. Amplified phage populations, each expressing a single peptide, were tested first in pools and then one by one for their ability to inhibit binding of human anti-gliadin antibodies in ELISA assays. These experiments showed that several of the different peptide-expressing phage tested inhibited the interaction between gliadin and anti-gliadin antibodies. Finally, four different peptide-encoding sequences were selected for further analysis, and the corresponding 12-mer peptides were synthesised <jats:italic>in vitro<\/jats:italic>. By ELISA assays it was demonstrated that several of the peptides inhibited the interaction between gliadin molecules and serum anti-gliadin antibodies. Moreover, ELISA competition experiments as well as dot-blot and western blot revealed that the different peptides interacted with different molecular sites of gliadin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We believe that several of the isolated and characterised gliadin-binding peptides described here could provide valuable tools for researchers in the field of CD by facilitating studies on localisation and uptake of various gliadin peptides in the small intestine. In future work, the potential of these peptides to detoxify gluten will be investigated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6750-11-16","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T19:14:57Z","timestamp":1297970097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of gliadin-binding peptides by phage display"],"prefix":"10.1186","volume":"11","author":[{"given":"Tingsu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"\u00d6stman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Sofie","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"576_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.169.1.345","volume":"169","author":"LM Sollid","year":"1989","unstructured":"Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E: Evidence of a primary association of celiac disease to a particular HLA-DQ alpha\/beta heterodimer. J Exp Med. 1989, 169: 345-350. 10.1084\/jem.169.1.345.","journal-title":"J Exp Med"},{"key":"576_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","volume":"18","author":"LM Sollid","year":"2000","unstructured":"Sollid LM: Molecular basis of celiac disease. Ann Rev Immunol. 2000, 18: 53-81. 10.1146\/annurev.immunol.18.1.53.","journal-title":"Ann Rev Immunol"},{"key":"576_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1053\/gast.2001.22123","volume":"120","author":"A Fasano","year":"2001","unstructured":"Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001, 120: 636-651. 10.1053\/gast.2001.22123.","journal-title":"Gastroenterology"},{"key":"576_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(96)90540-1","volume":"347","author":"M Hadjivassiliou","year":"1996","unstructured":"Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A: Does cryptic gluten sensitivity play a part in neurological illness?. Lancet. 1996, 347: 369-371. 10.1016\/S0140-6736(96)90540-1.","journal-title":"Lancet"},{"key":"576_CR5","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(96)70237-4","volume":"349","author":"M Maki","year":"1997","unstructured":"Maki M, Collin P: Coeliac disease. Lancet. 1997, 349: 1755-1759. 10.1016\/S0140-6736(96)70237-4.","journal-title":"Lancet"},{"key":"576_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00001574-200403000-00008","volume":"20","author":"G Robins","year":"2004","unstructured":"Robins G, Howdle PD: Advances in celiac disease. Curr Opin Gastroenterol. 2004, 20: 95-103. 10.1097\/00001574-200403000-00008.","journal-title":"Curr Opin Gastroenterol"},{"key":"576_CR7","doi-asserted-by":"crossref","unstructured":"Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, et al: The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology. 2005, 128 (4 SUPPL 1):","DOI":"10.1053\/j.gastro.2005.02.014"},{"key":"576_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1001\/archinte.163.3.286","volume":"163","author":"A Fasano","year":"2003","unstructured":"Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PHR, Guandalini S, Hill ID, et al: Prevalence of Celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med. 2003, 163: 286-292. 10.1001\/archinte.163.3.286.","journal-title":"Arch Intern Med"},{"key":"576_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2036.2007.03502.x","volume":"26","author":"S Lohi","year":"2007","unstructured":"Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, Lohi O, Bravi E, Gasparin M, Reunanen A, et al: Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007, 26: 1217-1225. 10.1111\/j.1365-2036.2007.03502.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"576_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.gastro.2009.03.059","volume":"137","author":"A Rubio-Tapia","year":"2009","unstructured":"Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, et al: Increased Prevalence and Mortality in Undiagnosed Celiac Disease. Gastroenterology. 2009, 137: 88-93. 10.1053\/j.gastro.2009.03.059.","journal-title":"Gastroenterology"},{"key":"576_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997, 3: 797-801. 10.1038\/nm0797-797.","journal-title":"Nat Med"},{"key":"576_CR12","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I","volume":"31","author":"O Molberg","year":"2001","unstructured":"Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM: T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase. Eur J Immunol. 2001, 31: 1317-1323. 10.1002\/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I.","journal-title":"Eur J Immunol"},{"key":"576_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0016-5085(98)70134-9","volume":"115","author":"EM Nilsen","year":"1998","unstructured":"Nilsen EM, Jahnsen FL, Lundin KEA, Johansen FE, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P: Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology. 1998, 115: 551-563. 10.1016\/S0016-5085(98)70134-9.","journal-title":"Gastroenterology"},{"key":"576_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/(SICI)1521-3803(19990601)43:3<175::AID-FOOD175>3.0.CO;2-Z","volume":"43","author":"M Silano","year":"1999","unstructured":"Silano M, De Vincenzi M: Bioactive antinutritional peptides derived from cereal prolamins: A Review. Nahrung - Food. 1999, 43: 175-184. 10.1002\/(SICI)1521-3803(19990601)43:3<175::AID-FOOD175>3.0.CO;2-Z.","journal-title":"Nahrung - Food"},{"key":"576_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(96)03060-7","volume":"348","author":"A Picarelli","year":"1996","unstructured":"Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei L: Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. The Lancet. 1996, 348: 1065-1067. 10.1016\/S0140-6736(96)03060-7.","journal-title":"The Lancet"},{"key":"576_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1365-3083.1998.00244.x","volume":"47","author":"R Saalman","year":"1998","unstructured":"Saalman R, Wold AE, Dahlgren UI, Fallstrom SP, Hanson LA, Ahlstedt S: Antibody-dependent cell-mediated cytotoxicity to gliadin-coated cells with sera from children with coeliac disease. Scand J Immunol. 1998, 47: 37-42. 10.1046\/j.1365-3083.1998.00244.x.","journal-title":"Scand J Immunol"},{"key":"576_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.191.4.603","volume":"191","author":"H Arentz-Hansen","year":"2000","unstructured":"Arentz-Hansen H, K\u00f6rner R, Molberg O, Quarsten H, Vader W, Kooy YMC, Lundin KEA, Koning F, Roepstorff P, Sollid LM, et al: The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Experimen Med. 2000, 191: 603-612. 10.1084\/jem.191.4.603.","journal-title":"J Experimen Med"},{"key":"576_CR18","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.1074129","volume":"297","author":"L Shan","year":"2002","unstructured":"Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C: Structural basis for gluten intolerance in celiac sprue. Science. 2002, 297: 2275-2279. 10.1126\/science.1074129.","journal-title":"Science"},{"key":"576_CR19","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1053\/gast.2002.33606","volume":"122","author":"W Vader","year":"2002","unstructured":"Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Pea S, Mearin L, Drijfhout JW, Koning F: The Gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology. 2002, 122: 1729-1737. 10.1053\/gast.2002.33606.","journal-title":"Gastroenterology"},{"key":"576_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1046\/j.1365-3083.1998.00397.x","volume":"48","author":"L Sj\u00f6str\u00f6m","year":"1998","unstructured":"Sj\u00f6str\u00f6m L, Molberg , K\u00f6rner , Mcadam , Anthonsen , Quarsten , Nor\u00e9n , Roepstorff , Thorsby , Sollid : Identification of a Gliadin T-Cell Epitope in Coeliac Disease: General Importance of Gliadin Deamidation for Intestinal T-Cell Recognition. Scand J Immunol. 1998, 48: 111-115.","journal-title":"Scand J Immunol"},{"key":"576_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2004.06.020","volume":"21","author":"B Meresse","year":"2004","unstructured":"Meresse B, Chen ZG, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, et al: Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004, 21: 357-366. 10.1016\/j.immuni.2004.06.020.","journal-title":"Immunity"},{"key":"576_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","volume":"21","author":"S Hue","year":"2004","unstructured":"Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, et al: A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease. Immunity. 2004, 21: 367-377. 10.1016\/j.immuni.2004.06.018.","journal-title":"Immunity"},{"key":"576_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0140-6736(03)13803-2","volume":"362","author":"L Maiuri","year":"2003","unstructured":"Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, Londei M: Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet. 2003, 362: 30-37. 10.1016\/S0140-6736(03)13803-2.","journal-title":"Lancet"},{"key":"576_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3001012","volume":"2","author":"J Tye-Din","year":"2010","unstructured":"Tye-Din J, Steward JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell D, et al: Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med. 2010, 2: 1-14.","journal-title":"Sci Transl Med"},{"key":"576_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ncpgasthep0111","volume":"2","author":"LM Sollid","year":"2005","unstructured":"Sollid LM, Khosla C: Future therapeutic options for celiac disease. Nat Clin Pract Gastroenterol Hepatol. 2005, 2: 140-147. 10.1038\/ncpgasthep0111.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"576_CR26","doi-asserted-by":"publisher","first-page":"G621","DOI":"10.1152\/ajpgi.00034.2006","volume":"291","author":"D Stepniak","year":"2006","unstructured":"Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van Veelen P, Edens L, Koning F: Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Am J Physiol Gastrointest Liver Physiol. 2006, 291: G621-G629. 10.1152\/ajpgi.00034.2006.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"576_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/bit.20643","volume":"92","author":"J Gass","year":"2005","unstructured":"Gass J, Ehren J, Strohmeier G, Isaacs I, Khosla C: Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: Implications for celiac sprue therapy. Biotech Bioeng. 2005, 92: 674-684. 10.1002\/bit.20643.","journal-title":"Biotech Bioeng"},{"key":"576_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.clim.2009.11.001","volume":"134","author":"J Tye-Din","year":"2010","unstructured":"Tye-Din J, Anderson RP, Ffrench RA, Brown GJ, Hodsman P, Siegel M, Botwick W, Shreeniwas R: The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol. 2010, 134: 289-295. 10.1016\/j.clim.2009.11.001.","journal-title":"Clin Immunol"},{"key":"576_CR29","unstructured":"Alvine Pharmaceutical: A phase 2a, double-blind, placebo controlled study of the efficacy, safety and tolerability of 6-weeks tratment with ALV003 in patients with well-controlled celiac disease. ClinicalTrialsgov [Internet]. Bethesda (MD): National Library of Medicine (US), 2000-[cited 2011 Jan 14] NLM Identifier: NTC00004451, [http:\/\/clinicaltrials.gov\/show\/NCT00959114]"},{"key":"576_CR30","unstructured":"Nexpep Pty Ltd: A phase I study to determine safety, tolerability and bioactivity of Nexvax2 in HLA DQ2+ volunteers with coeliac disease following a long-term strict gluten-free diet. ClinicalTrialsgov [Internet]. Bethesds (MD): National Library of Medicine (US), 2000-[cited 2011 Jan 14], NLM Identifier: NTC00879749., [http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00879749]"},{"key":"576_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","volume":"26","author":"BM Paterson","year":"2007","unstructured":"Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB: The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: A proof of concept study. Aliment Pharmacol Ther. 2007, 26: 757-766. 10.1111\/j.1365-2036.2007.03413.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"576_CR32","unstructured":"Alba Therapeutics: A phase IIb, randomised, double-blind, placebo controlled, dose ranging, multicenter study to determine the safety, tolerance and efficacy of AT-1001 in celiac disease subjects during a gluten challenge. ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US), 2000-[2011 Jan 14]., [http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00889473]"},{"key":"576_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bbadis.2005.09.008","volume":"1762","author":"AM De ngelis","year":"2006","unstructured":"De ngelis AM, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M, De Vincenzi M, Losito I, Gobbetti M: VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue. Biochim Biophys Acta. 2006, 1762: 80-93.","journal-title":"Biochim Biophys Acta"},{"key":"576_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1053\/j.gastro.2008.09.016","volume":"136","author":"M Pinier","year":"2009","unstructured":"Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vezina A, Rivard N, Leroux JC: Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology. 2009, 136: 288-298. 10.1053\/j.gastro.2008.09.016.","journal-title":"Gastroenterology"},{"key":"576_CR35","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.4001944","volume":"228","author":"GP Smith","year":"1985","unstructured":"Smith GP: Filamentous fusion phage: Novel expression vectors that display cloned antigens on the viron surface. Science. 1985, 228: 1315-1317. 10.1126\/science.4001944.","journal-title":"Science"},{"key":"576_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1074-5521(00)00062-4","volume":"7","author":"R Hyde-DeRuyscher","year":"2000","unstructured":"Hyde-DeRuyscher R, Page LA, Christiansen DJ, Hyde-DeRuyscher N, Lim A, Fredricks ZL, Kranz J, Gallant P, Zhang J, Rocklage SM, et al: Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptides libraries. Chem Biol. 2000, 7: 17-25. 10.1016\/S1074-5521(00)00062-4.","journal-title":"Chem Biol"},{"key":"576_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0049-3848(02)00349-3","volume":"107","author":"MS Meiring","year":"2002","unstructured":"Meiring MS, Litthauer D, Harsfalvi J, Van Wyk V, Badenhorst PN, Kotze HF: In vitro effect of a thrombin inhibition peptide selected by phage display technology. Thromb Res. 2002, 107: 365-371. 10.1016\/S0049-3848(02)00349-3.","journal-title":"Thromb Res"},{"key":"576_CR38","first-page":"65","volume-title":"Proceedings of the 16th Meeting of Working Group of Prolamin Analysis and Toxicity: 2002","author":"K el Tayeb Khallafalla","year":"2002","unstructured":"el Tayeb Khallafalla K, Osman AA, Langer M, Mothes T: Affinity peptides for gluten analysis?. Proceedings of the 16th Meeting of Working Group of Prolamin Analysis and Toxicity: 2002. 2002, Verlag Wissenschaftliche Scripten, 65-70."},{"key":"576_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0922-338X(98)80093-7","volume":"85","author":"Y Katakura","year":"1998","unstructured":"Katakura Y, Lim ET, Tsujii S, Omasa T, Suga KI: The importance of ionic strength as a parameter in screening peptide ligands from a phage display library. J Fermentat Bioengineer. 1998, 85: 447-450. 10.1016\/S0922-338X(98)80093-7.","journal-title":"J Fermentat Bioengineer"},{"key":"576_CR40","first-page":"447","volume-title":"Food chemistry","author":"OR Fennema","year":"1996","unstructured":"Fennema OR: Food chemistry. Edited by: Inc MD. 1996, 447-450."},{"key":"576_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/(SICI)1097-0010(199811)78:3<423::AID-JSFA135>3.0.CO;2-6","volume":"78","author":"B Mimouni","year":"1998","unstructured":"Mimouni B, Robin JM, Azanza JL, Raymond J: Wheat flour proteins: Isolation and functionality of gliadin and HMW-glutenin enriched fractions. J Sci Food Agric. 1998, 78: 423-428. 10.1002\/(SICI)1097-0010(199811)78:3<423::AID-JSFA135>3.0.CO;2-6.","journal-title":"J Sci Food Agric"},{"key":"576_CR42","unstructured":"Shewry PR, (ed.): Wheat gluten protein analysis. St Paul. 2003"},{"key":"576_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1094\/CCHEM-85-1-0001","volume":"85","author":"H Wieser","year":"2008","unstructured":"Wieser H, Koehler P: The biochemical basis of celiac disease. Cereal Chem. 2008, 85: 1-13. 10.1094\/CCHEM-85-1-0001.","journal-title":"Cereal Chem"},{"key":"576_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/73200","volume":"6","author":"RP Anderson","year":"2000","unstructured":"Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AVS: In vivo challenge in celiac disease identifies a single transglutaminase-modified peptides as the dominant A-gliadin T-cell epitope. Nat Med. 2000, 6: 337-342. 10.1038\/73200.","journal-title":"Nat Med"},{"key":"576_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nri885","volume":"2","author":"LM Sollid","year":"2002","unstructured":"Sollid LM: Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002, 2: 647-655. 10.1038\/nri885.","journal-title":"Nat Rev Immunol"},{"key":"576_CR46","doi-asserted-by":"publisher","first-page":"10150","DOI":"10.1021\/jf902268z","volume":"57","author":"K Hoffmann","year":"2009","unstructured":"Hoffmann K, Alminger M, Andlid T, Chen T, Olsson O, Sandberg AS: Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro. J Agric Food Chem. 2009, 57: 10150-10155. 10.1021\/jf902268z.","journal-title":"J Agric Food Chem"},{"key":"576_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.biotechadv.2005.05.005","volume":"23","author":"RJ Hamer","year":"2005","unstructured":"Hamer RJ: Coeliac Disease: Background and biochemical aspects. Biotech Adv. 2005, 23: 401-408. 10.1016\/j.biotechadv.2005.05.005.","journal-title":"Biotech Adv"},{"key":"576_CR48","first-page":"41","volume-title":"Second International Symposium on Gluten-Free Cereal Products and Beverages","author":"T Thompson","year":"2010","unstructured":"Thompson T: Nutritional Requirements for Gluten-Free Foods. Second International Symposium on Gluten-Free Cereal Products and Beverages. 2010, Tampere, Finland, 41-42."},{"key":"576_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/011542650602100101","volume":"21","author":"J See","year":"2006","unstructured":"See J, Murray JA: Gluten-free diet: The medical and nutritional management of celiac disease. Nutr Clin Pract. 2006, 21: 1-15. 10.1177\/011542650602100101.","journal-title":"Nutr Clin Pract"},{"key":"576_CR50","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00217-003-0786-0","volume":"217","author":"S Storsrud","year":"2003","unstructured":"Storsrud S, Malmheden Yman I, Lenner RA: Gluten contamination in oat products and products naturally free from gluten. Eur Food Res Technol. 2003, 217: 481-485. 10.1007\/s00217-003-0786-0.","journal-title":"Eur Food Res Technol"},{"key":"576_CR51","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/00005176-198609000-00011","volume":"5","author":"V Kumar","year":"1986","unstructured":"Kumar V, Jain N, Lerner A, Beutner EH, Chorzelski TP, Lebenthal E: Comparative studies of different gliadin in detecting antigliadin antibodies. J Pediatr Gastroenterol Nutr. 1986, 5: 730-734. 10.1097\/00005176-198609000-00011.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"576_CR52","first-page":"418","volume":"104","author":"C Murr","year":"1992","unstructured":"Murr C, Ellemunter H, Oberhuber G, Hoffmann Y, Schmoigl C, Pillwein K: Gliadin IgA antibodies in diagnosis of celiac disease in childhood. Wien Klin Wochenschr. 1992, 104: 418-422.","journal-title":"Wien Klin Wochenschr"},{"key":"576_CR53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/00365520802449328","volume":"44","author":"A Eisenmann","year":"2009","unstructured":"Eisenmann A, Murr C, Fuchs D, Ledochowski M: Gliadin IgG antibodies and circulating immune complexes. Scand J Gastroenterol. 2009, 44: 168-171. 10.1080\/00365520802449328.","journal-title":"Scand J Gastroenterol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6750-11-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:01:55Z","timestamp":1630501315000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiotechnol.biomedcentral.com\/articles\/10.1186\/1472-6750-11-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,17]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1186\/1472-6750-11-16","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,17]]},"assertion":[{"value":"20 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"16"}}